NCT05052905

Brief Summary

The primary objective of this study is to evaluate the feasibility and effectiveness of an at-home program of VR-based vestibular and oculomotor rehabilitation on improving postural stability, ocular motility and activities of daily living for children with mild to severe ABI

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 22, 2021

Completed
23 days until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

December 12, 2023

Status Verified

December 1, 2023

Enrollment Period

1.2 years

First QC Date

August 25, 2021

Last Update Submit

December 9, 2023

Conditions

Keywords

Pediatric

Outcome Measures

Primary Outcomes (8)

  • Vestibular Oculomotor Motor Screening (VOMS)

    Symptoms scoring from 0 (none) to 10 (severe)

    6 months

  • Pediatric Vestibular Symptom Questionnaire (PVSQ)

    Score ranging from 0 (never) to 33 (most of the time) with a 4-Likert scale

    6 months

  • Convergence Insufficiency Symptom Survey (CISS)

    Score ranging from 0 (never) to 56 (Always) with a 5-Likert scale

    6 months

  • Dizziness Handicap Inventory (DHI)

    Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale

    6 months

  • Dizziness Handicap Inventory for patients caregivers (DHI-PC)

    Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale

    6 months

  • Pediatric Quality of Life Inventory (PEDSQL)

    Score ranging from 0 (worst) to 100 (best) with a 5-Likert scale

    6 months

  • Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)

    Time score ranging from 0 (unable to complete) to 120 (completed successfully) in one of three 30-seconds trials and four conditions

    6 months

  • Berg Balance Scale (Berg)

    Score ranging from 0 (lowest level of function) to 56 (highest level of function) with a 5-Likert scale

    6 months

Study Arms (1)

Study

EXPERIMENTAL

Exercises

Device: LibraVR

Interventions

LibraVRDEVICE

LibraVR is a standalone VR-based rehabilitation software for use in physiotherapy. It is designed to work with standard off-the-shelf hardware that is tested and approved for use in conjunction with the software. LibraVR system consists of the software (LibraVR Clinic) running on a PC (database of patients, creation of protocols, uploading protocols to mobile), and the LibraVR Mobile APP that runs on commercial mobile smartphones embedded in a lightweight cardboard or plastic VR viewer that the child wears as they would eyeglasses. The software displays a range of immersive VR exercises.

Study

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • They are ALYN patients undergoing physiotherapy for mild to severe ABI;
  • They experience symptoms of vestibular function such as vertigo, postural instability, or impaired ocular motility;
  • They are between the ages of 8 and 18;
  • The time since injury/event is between 10 days and 1 year after the injury/event;
  • They are able to maintain stable and dynamic positioning of the head;
  • They able to walk with or without assistive equipment, or use a wheelchairs with no need for head support, defined by a LSS (level of sitting scale) score of 3 or greater (scale range: 1-8);
  • Are able to understand basic instructions;
  • Have sufficient visual acuity and visual field to identify and track mid-size objects on a screen.

You may not qualify if:

  • Psychological, neurological or cognitive disorders which could impede participation, such as a history of epileptic seizures;
  • Untreated benign paroxysmal positional vertigo (BPPV);
  • Are in early post-operative stages (to avoid risk of bleeding or cerebrospinal fluid leak);
  • Hearing impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ALYN Hospital Pediatric and Adolescent Rehabilitation Center

Jerusalem, Israel

Location

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Naomi Gefen

    ALYN Hospital Pediatric and Adolescent Rehabilitation Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2021

First Posted

September 22, 2021

Study Start

October 15, 2021

Primary Completion

December 15, 2022

Study Completion

April 1, 2023

Last Updated

December 12, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations